美国药品价格改革政策的新动向

New trend of drug price reform in the United States

近期,美国白宫提出了"美国病人优先"(American Patients First)的口号来推动美国处方药的价格改革,主要措施包括通过市场竞争和支付方的价格谈判,降低创新药品价格;对享受联邦医疗保险处方药计划(Medicare Part D)的病人自费封顶,并将在5个州进行医疗补助计划(Medicaid),选择药品补助覆盖的品种和支付方式进行试点;要求医院公示药品价格,让病人有更多的就医选择权;计划将推行包括50多项降低昂贵药品价格的措施。笔者分析了美国药品价格改革的起因、改革政策的主要内容和方向,并指出了对我国药品价格改革的启示。

eRecently,the White House of USA proposed a slogan of＂American patients first＂to promote prescription drugs＇ price in the United States. Main measures include reducing the price of innovative drugs through the market competition and price negotiations, capping the patients＇ copayment of Medicare part D prescription drug plan,and piloting the selection of drug coverage and payment models in Medicaid program in five States. Require the hospital to show the price of drug so that the patients can have more medicine options. The plan will include more than 50 moves to reduce the price of expensive and innovative drugs. The paper focuses on the causes of drug price reform in the United States,main contents and directions of reform policies,and the enlightenment to China＇s drug price reform.簸